DELIA GONGORA: Open Payments
NPI 1790185353 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,755 in 128 payments from 30 companies in 2025. Trend: 2023 $2,319 · 2024 $2,666 · 2025 $2,755
Food & beverage: $2,755
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $398 |
| SHIELD THERAPEUTICS INC | 3 | $345 |
| Novartis Pharmaceuticals Corporation | 12 | $240 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $193 |
| Novo Nordisk Inc | 12 | $192 |
| AstraZeneca Pharmaceuticals LP | 9 | $190 |
| Lilly USA, LLC | 8 | $148 |
| ABBVIE INC. | 6 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $93 |
| GlaxoSmithKline, LLC. | 4 | $84 |
Products named: ACCRUFER, LEQVIO, Kerendia, OTEZLA, MOUNJARO, CREON, XIFAXAN, JARDIANCE.
Industry payments across FL — which companies pay providers there.
